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Abstract
Background: Exposure to Staphylococcal Enterotoxin B (SEB), a bacterial superantigen secreted
by the Gram-positive bacteria Staphyloccocus aureus, results in the expansion and eventual clonal
deletion and anergy of Vβ8+ T cells, as well as massive cytokine release, including Interleukin-2 (IL-
2). This IL-2 is rapidly secreted following exposure to SEB and may contribute to the symptoms
seen following exposure to this bacterial toxin. The Tec family kinase ITK has been shown to be
important for the production of IL-2 by T cells stimulated in vitro and may represent a good target
for blocking the production of this cytokine in vivo. In order to determine if ITK represents such a
target, mice lacking ITK were analyzed for their response to SEB exposure.
Results: It was found that T cells from mice lacking ITK exhibited significantly reduced proliferative
responses to SEB exposure in vitro, as well as in vivo. Examination of IL-2 production revealed that
ITK null mice produced reduced levels of this cytokine in vitro, and more dramatically, in vivo. In vivo
analysis of c-jun phosphorylation, previously shown to be critical for regulating IL-2 production,
revealed that this pathway was specifically activated in SEB reactive Vβ8+ (but not non-reactive
Vβ6+) T cells from WT mice, but not in Vβ8+ T cells from ITK null mice. However, toxicity analysis
indicated that both WT and ITK null animals were similarly affected by SEB exposure.
Conclusion: These data show that ITK is required for IL-2 production induced by SEB in vivo, and
may regulate signals leading IL-2 production, in part by regulating phosphorylation of c-jun. The data
also suggest that perturbing T cell activation pathways leading to IL-2 does not necessarily lead to
improved responses to SEB toxicity.
Background
Superantigens (SAGs) are microbial toxins of bacterial
and viral origin with the ability to activate 5–20% of the T
cell population, causing T cell activation, cytokine release
and systemic shock [1,2]. Most SAGs share the ability to
simultaneously bind the class II major histocompatibility
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complex molecules and the variable region of the T cell
receptor β-chain, without the need to be processed by
antigen presenting cells [1,2]. Thus SEB can interact
directly with MHC class II molecules on APCs and activate
T cells bearing the proper TcR Vβ chains. The result of this
interaction is large-scale stimulation of any T cell that
expresses the proper TCR Vβ chain. A number of studies
have shown that when mice are challenged with a SAG
such as Staphylococcal Enterotoxin B (SEB), toxicity
results from massive induction of cytokines derived from
T-helper-type-1 (TH1) type cells such as IL-2, IFN-γ, TNF-α
and TNF-β [1,3]. This cytokine production is accompa-
nied by expansion of the numbers of SEB reactive T cells,
followed by cell death and the induction of functional
"anergy" [4-6].
In order for a T cell to be activated antigen presenting cells
(APC) must present antigen, either an antigenic peptide or
SAG. In vitro, this interaction with the TcR has been shown
to lead to the activation of a number of tyrosine kinases,
including the Src family kinase Lck, the Syk family kinase
Zap-70 and the Tec family kinase ITK (for review see [7-
10]). This then results in the activation of a number of sig-
naling pathways including members of the MAPK family
of kinases, ERK, JNK and p38, followed by transcription
factor activation [10]. In vivo, activation of these T cells
lead to the induction of cytokine secretion within hours of
SEB exposure [1,3].
ITK is expressed primarily in T cells, NK cells and mast
cells [11-13]. In T cells, it is rapidly activated following
TcR crosslinking in vitro [14,15]. Mice lacking ITK exhibit
reduced proliferation and IL-2 production in vitro, and
reduced T cell differentiation in vitro and in vivo, with TH2
cell differentiation preferentially affected [15-19]. The
observed reduced proliferation of ITK null T cells in vitro
is IL-2 dependent as it could be rescued by the addition of
exogenous IL-2 [20]. However, these animals are not
entirely immunocompromised, with residual responses
against LCM, Vaccinia and VS viruses [21]. We have tested
whether ITK null mice are susceptible to SEB induced IL-2
secretion. We show here that mice lacking ITK have much
reduced IL-2 production and T cell expansion in response
to SEB in vitro and in vivo. We also show that SEB induced
the activation of the JNK MAPK pathway in responding T
cells in vivo, and that ITK null T cells were defective in the
activation of this pathway in vivo. However, toxicity anal-
ysis indicated that both WT and ITK null animals were
similarly affected by SEB exposure. Our data suggest that
ITK is required for full IL-2 secretion following SEB expo-
sure, and that this may be due to the regulation of the JNK
pathway by ITK in vivo. However, reducing T cell signals
does not necessarily lead to better physiological responses
to SEB exposure.
Results
ITK deficient T cells proliferate less efficiently than WT T 
cells in response to varying concentrations of SEB in vitro
It has previously been reported that T cells from mice lack-
ing ITK exhibit much reduced proliferation in response to
anti-CD3 or TcR antibodies in vitro [15,16,18]. By con-
trast, these T cells did not have any defects and actually
had higher proliferative responses following anti-CD28/
PMA stimulation [20]. These data do not provide clear
answers as to whether ITK would present a good target for
inhibition of SEB induced T cell activation in vivo, and in
particular, in the cytokine response observed following
SAG exposure. We therefore first tested whether ITK null T
cells could respond to SEB stimulation by proliferation in
vitro. Pooled splenocytes and lymph node cells from WT
or ITK null animals were cultured in vitro in the presence
of varying concentrations of SEB (5 µg/ml, 0.5 µg/ml, 0.05
µg/ml, 0.005 µg/ml, and 0.0005 µg/ml), and proliferation
analyzed over a 5-day period. We found that WT cells
responded normally by proliferating between days 2 and
3, with maximum proliferation observed at day 5 and the
5  µg/ml dose of SEB (Fig. 1a). Analysis of the dose
response at 5 days indicated that the WT cells responded
in a dose dependent fashion (Fig. 1b). By contrast, cells
from ITK mice showed very little response, regardless of
the dose of SEB used for stimulation (Fig. 1a, b). We next
determined if the same results would be obtained in puri-
fied T cell populations from these mice. T cells were puri-
fied from WT and ITK null mice, and stimulated with
varying dose of SEB, in the presence of APCs. Analysis of
the data over the 5 days indicated that in the presence of
the highest concentration of SEB tested (10 µg/ml), WT T
cells responded more robustly than ITK null T cells (see
Fig. 1c). Indeed, at all the doses tested, our analysis indi-
cated that ITK null T cells responded less than WT T cells
on day 3, 4 and 5 (Fig. 1d–f), while proliferation was
equivalent when PMA and Ionomycin was used to bypass
TcR signals (data not shown). These data indicate that ITK
null T cells have significantly reduced proliferative
responses to SEB in vitro.
ITK null T cells secrete less IL-2 in response to SEB in vitro
Interleukin-2 is one of the cytokines induced by exposure
to SEB [22]. ITK has been shown to regulate IL-2 secretion
in vitro by T cells stimulated anti-CD3/TcR antibodies or
in response to peptide antigen [15,18,23,24]. We there-
fore determined the levels of IL-2 in supernatants from
cells similarly stimulated with SEB in vitro (Fig. 2). While
WT T cells responded to SEB by secretion of IL-2 within 24
hrs. of stimulation in a dose dependent manner (see Fig.
2a for 5 µg/ml dose), starting at the 0.5 µg/ml SEB concen-
tration (Fig. 2bi), ITK null T cells made very little IL-2, and
the small amount of IL-2 that was made was only at the
highest concentration of SEB tested (5 µg/ml). ITK null T
cells consistently secreted less IL-2 over the 5-day periodBMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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and dose range (Fig. 2b). These data indicate that as pre-
viously reported for TcR or antigenic stimulation, ITK reg-
ulates the production of IL-2 in vitro in response to SEB
stimulation [15,18,23,24].
Reduced expansion of Vβ8+CD4+ population in ITK null 
animals in response to SEB exposure in vivo
While these data indicate that ITK regulates T cell prolifer-
ation in response to SEB in vitro, it is possible that within
ITK regulates proliferation in vitro in response to SEB Figure 1
ITK regulates proliferation in vitro in response to SEB. Splenocytes and lymph node cells from WT (filled circles) and 
ITK deficient (open circles) mice were stimulated in vitro with the indicated concentrations of SEB, and proliferative response 
determined. Time course of proliferation over the indicated doses of SEB a) 5 µg/ml SEB, b) dose curve of 0.0005, 0.005, 0.05, 
0.5, & 5 µg/ml SEB analyzed at 5 days post stimulation. Purified WT (filled circles) and ITK deficient (open circles) T cells were 
stimulated in vitro over the indicated time with c) 10 µg/ml SEB, or a dose curve of 0.01, 0.1, 1, and 10 µg/ml SEB and analyzed 
at d) 3 days, e) 4 days or f) 5 days post stimulation. * indicates statistically significant difference with a p < 0.05.BMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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ITK regulates IL-2 secretion in vitro in response to SEB Figure 2
ITK regulates IL-2 secretion in vitro in response to SEB. Splenocytes and lymph node cells from WT (filled circles) or 
ITK deficient (open circles) mice were stimulated in vitro with the indicated concentrations of SEB and IL-2 levels secreted in 
supernatants determined. a) Time course of IL-2 secretion at 5 µg/ml SEB dose. b) IL-2 secretion over the indicated times and 
doses. (i) Day 1; (ii) Day 2; (iii) Day 3; (iv) Day 4 and (v) Day 5. * indicates statistically significant difference with a p < 0.05.BMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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the context of antigen presentation and optimal co-stimu-
latory signals in vivo, ITK null T cells may exhibit a better
response. Exposure of animals to SEB results in an
expansion of the SEB reactive T cell population with a
peak of around 2 days post exposure [2,4]. In order to
determine if the reduced proliferative responses seen with
the ITK null T cells in vitro was also seen in vivo, we
exposed WT and ITK null animals to SEB and determined
the percentages of Vβ8 and Vβ6 positive cells in the CD4+
population by flow cytometry after 2, 4 and 5 days as a
measure of T cell expansion. T cells bearing Vβ8 TcR
chains are responsive to SEB stimulation while those that
bear Vβ6 TcR chains are not, so we analyzed these two
populations of T cells. As previously reported, in WT ani-
mals, we observed an approximately 4 fold expansion in
Vβ8 CD4+  T cells in spleen and lymph nodes following
SEB exposure (as compared to exposure to PBS, fig 3a,b),
while Vβ6 CD4+ T cell populations were largely
unchanged (data not shown). By contrast, there was statis-
tically significantly less expansion of ITK null Vβ8+CD4+ T
cells following SEB exposure, although these cells still
expanded (Fig. 3a,b) As previously reported, the percent-
ages of T cells bearing Vβ6 did not change over this period
in either the WT or ITK null mice (data not shown and
[4]). Thus the absence of ITK results in reduced T cell
expansion in vivo in response to SEB. 
Defective SEB induced IL-2 secretion in vivo in ITK null 
mice
T cells from ITK null mice proliferate less in vitro and in
vivo, and secrete significantly less IL-2 in vitro in response
to SEB. We therefore determined if they would also secrete
less IL-2 following SEB stimulation in vivo. Groups of mice
were exposed to SEB i.v. and at various time points their
serum was taken and analyzed for IL-2 production. We
found that in comparison to in vitro IL-2 production,
when WT mice were exposed to SEB in vivo they produced
IL-2 within 1 hr., which peaked at around 2 hrs. (Fig. 4).
In addition, consistent with the in vitro stimulation, ITK
Reduced T cell expansion in response to SEB exposure in vivo Figure 3
Reduced T cell expansion in response to SEB expo-
sure in vivo. a) WT (filled circles) or ITK deficient mice 
(open circles) were injected with 50 µg SEB i.p. and periph-
eral blood lymphocytes analyzed after 2, 4 and 5 days as in 
the materials and methods for the percentage of Vβ8+CD4+ 
T cells as indicated (Vβ6+CD4+ T cells showed no change, 
data not shown). b) The same data plotted as fold increase in 
percentage of Vβ8+CD4+ T cells in peripheral blood. * indi-
cates a statistically significant difference with a p < 0.05.
ITK null mice secrete less IL-2 in response to SEB exposure  in vivo Figure 4
ITK null mice secrete less IL-2 in response to SEB 
exposure in vivo. WT (filled circles) and ITK deficient 
(open circles) mice were injected i.v. with 50 µg SEB and 
blood sampled after 1, 2, 4, 8, 12 and 24 hrs. post injection. 
IL-2 in serum was determined by ELISA.BMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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deficient mice secrete significantly less IL-2 in response to
SEB in vivo (Fig. 4). Based on these data we conclude that
in vivo IL-2 production occurs earlier than observed in
vitro, and that ITK null T cells continue to exhibit defects
in IL-2 production in response to SEB in vivo, even in the
presumed presence of adequate costimulatory signals in
vivo.
Defective phosphorylation of c-jun induced by SEB in ITK 
null T cells
The JNK MAPK pathway has been shown to be essential
for IL-2 production upon stimulation of T cells by the TcR
and CD28 in vitro [25-28]. This pathway leads to phos-
phorylation of c-jun and activation of an AP-1 transcrip-
tion factor complex that is required for IL-2 transcription
[28]. While activation of the JNK pathway leading to
phosphorylation and activation of c-jun has been demon-
strated in T cells following TcR and CD28 crosslinking in
vitro, as well as by peptide antigen stimulation in vivo, it is
not clear whether the SAG SEB activates this pathway in
vivo  [29,30]. We therefore tested whether SEB could
induce phosphorylation of c-jun in WT T cells stimulated
with SEB in vivo. To do this, we adapted a method initially
used by Jenkins and colleagues to analyze phosphoryla-
tion of c-jun following in vivo exposure of antigen. In this
protocol, mice were exposed to SEB, then cells from
lymph nodes, spleen and blood rapidly isolated and fixed,
and antibodies specific for phosphorylated c-jun used to
analyze its phosphorylation. In addition, cells were
stained with antibodies specific to Vβ8 or Vβ6 to detect
SEB responsive and non-responsive T cells respectively.
Flow cytometry was employed to detect phosphorylation
of c-jun [30]. Figure 5 demonstrates that 1 hr. after
intravenous exposure to SEB, Vβ8+ SEB reactive T cells in
spleen and lymph nodes contain higher levels of phos-
phorylated c-jun (cf. Figs. 5a, b iii & iv). Similar results
were found in animals exposed to SEB i.p. (data not
shown). By contrast, T cells non-reactive to SEB in the
same animals, those bearing Vβ6+ TcRs, did not have any
increase in phosphorylated c-jun (cf. Figs. 5a, b, i & ii).
This demonstrates that in the same animal, only those T
cells that interact with and can be activated by SEB
respond by phosphorylation of c-jun, while at the same
time, those T cells that are not reactive are not activated,
demonstrating specificity. Similarly, animals injected with
PBS showed no such change in phosphorylated c-jun in
either the SEB reactive or non-reactive T cell populations,
indicating that this was an SEB mediated event (Fig. 5a–
b). Other controls including secondary reagents alone
demonstrate the specificity of antibody staining (data not
shown).
We next determined whether T cells lacking ITK could
induce c-jun phosphorylation in response to SEB activa-
tion  in vivo. ITK null mice were exposed to SEB as
described above, and phosphorylation of c-jun deter-
mined in Vβ8+ T cell population (SEB reactive) or Vβ6+ T
cell population (non-reactive) in the same animals. These
experiments show that in the absence of ITK, SEB does not
lead to phosphorylation of c-jun in either T cell popula-
tion (Fig. 6a–d). Thus, the absence of ITK results in the
lack of SEB phosphorylation of c-jun, which could affect
the ability of these T cells to produce IL-2. To determine if
this lack of c-jun phosphorylation in ITK null T cells in
response to SEB reflected global nonresponsiveness in
these cells, we determined whether these cells were indeed
activated by SEB exposure. To do this, we measured
increases in CD69 expression, a cell surface protein that is
rapidly expressed by activated T cells in a Ras/MAPK
dependent manner [31-33]. Similar experiments were per-
formed as those examining c-jun phosphorylation, except
that we used specific antibodies against CD69 to deter-
mine if the SEB reactive cells had been activated. Figure 7
demonstrates that Vβ8+CD4+ T cells but not Vβ6+CD4+ T
cells from both WT and ITK null mice exhibited increases
in CD69 expression 2 hours following SEB exposure, indi-
cating that in both cases, the T cells were responding to
SEB activation (Fig. 7). However, SEB induced CD69
expression on a higher percentage of Vβ8+CD4+  SEB
responding T cells in WT mice than in ITK null mice (73.5
+/- 12% in WT vs. 43.6 +/- 0.5% in ITK null). However,
there was no difference in the MFI of CD69 expression WT
responding T cells vs. ITK null responding T cells (362.5
_+/- 6.3 in WT vs. 375 +/- 11.3 in ITK null). In addition,
there was no difference in the expression of CD25 on WT
or ITK null T cells (data not shown). Thus the lack of SEB
induced c-jun phosphorylation in ITK null T cells seems to
reflect the specific role of ITK in regulating this event in
response to SEB exposure in vivo.
Similar toxicity of SEB on WT and ITK null mice
Exposure of mice to SEB and LPS results in toxicity culmi-
nating in death [1]. We therefore analyzed the effect of
exposure to SEB/LPS on ITK null mice. However, in con-
trast to the results with IL-2 secretion and T cell expansion,
both mice were affected similarly (Table 1). Thus the same
proportion of mice became sick following exposure to
SEB and LPS, suggesting that although the absence of ITK
affects IL-2 secretion following SEB exposure, its absence
does not affect the ability of SEB to induce sickness in
these mice.
Discussion
It is well established that exposure to SEB results in large
scale cytokine production, which in part is responsible for
symptoms of exposure to this toxin [1,2,35]. T cells have
been shown to be largely responsible for this excessive
cytokine production [35,36]. Current suggestions for
pharmacologically blocking the symptoms of SEB
exposure include T cell signal transduction inhibitors suchBMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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SEB induces activation of the JNK pathway specifically in responding T cells in vivo Figure 5
SEB induces activation of the JNK pathway specifically in responding T cells in vivo. WT mice were injected with 50 
µg SEB or PBS i.v. and sacrificed after 1 hr. Spleen and lymph nodes were harvested and analyzed for the presence of phospho-
rylated c-jun in the Vβ8+ and Vβ6+ T cell populations. a) Spleen: (i) phosphorylation of c-jun in Vβ6+ T cells from PBS injected 
mice. (ii) phosphorylation of c-jun in Vβ6+ T cells from SEB injected mice. (iii) phosphorylation of c-jun in Vβ8+ T cells from 
the same PBS injected mice in (i). (iv) phosphorylation c-jun in Vβ8+ T cells from the same SEB injected mice in (ii). b) Lymph 
Node: (i) phosphorylation of c-jun in Vβ6+ T cells from PBS injected mice. (ii) phosphorylation of c-jun in Vβ6+ T cells from 
SEB injected mice. (iii) phosphorylation of c-jun in Vβ8+ T cells from the same PBS injected mice in (i). (iv) phosphorylation c-
jun in Vβ8+ T cells from the same SEB injected mice in (ii). Arrow points to the population of cells responding to SEB stimula-
tion by activation of the JNK pathway by inducing c-jun phosphorylation.BMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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as CsA and Perfenidone, however, these agents have
significant side effects [37,38]. Here we present a promis-
ing target for inhibition IL-2 production induced by SEB
exposure, the tyrosine kinase ITK. We show that mice lack-
ing ITK have significantly reduced T cell expansion and IL-
2 secretion upon exposure to SEB in vivo. Furthermore,
we show that the SEB induced signaling pathway leading
to c-jun phosphorylation, an indication of JNK pathway
activation, is significantly reduced in ITK null T cells,
although these T cells could respond to SEB activation by
upregulating CD69, and there was no difference in the
overall toxicity of SEB/LPS in these mice compared to WT
mice.
Previous work performed in vitro suggests that ITK is
required for the anti-TcR/CD3 antibody mediated activa-
tion of the transcription factor NFAT, via regulation of cal-
cium influx into TcR stimulated T cells [19,39]. ITK null T
cells also exhibit reduced AP-1 DNA binding activity when
stimulated in vitro with anti-CD3 antibodies [19]. It has
also been shown that JNK activation lies in part down-
stream of ITK following TcR crosslinking in vitro [23].
However, these experiments were performed in vitro and it
ITK is required for SEB mediated induction of c-jun phosphorylation in responding T cells in vivo Figure 6
ITK is required for SEB mediated induction of c-jun phosphorylation in responding T cells in vivo. WT (top pan-
els) or ITK null (bottom panels) mice were injected with 50 µg SEB or PBS i.v. and sacrificed after 1 hr. Splenocytes were then 
analyzed for the presence of phosphorylated c-jun in the Vβ8+ and Vβ6+ T cell populations. a) Vβ6+ T cells from WT mice; b) 
Vβ8+ T cells from WT mice; c) Vβ6+ T cells from ITK null mice; d) Vβ8+ T cells from ITK null mice.BMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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ITK is not necessary for SEB induced upregulation of CD69 inresponding T cells in vivo Figure 7
ITK is not necessary for SEB induced upregulation of CD69 inresponding T cells in vivo. WT (top panels) or ITK 
null (bottom panels) mice were injected with 50 µg SEB or PBS i.v. and sacrificed after 2 hrs. Splenocytes were then analyzed 
for the presence of CD69 on the Vβ8+ and Vβ6+ T cell populations. a) Vβ6+ T cells from WT mice; b) Vβ8+ T cells from WT 
mice; c) Vβ6+ T cells from ITK null mice; d) Vβ8+ T cells from ITK null mice.
Table 1: Effect of SEB on health and survival of WT and ITK null mice. Mice (WT or ITK null) were injected with the indicated amount 
of LPS, followed 4 hours later by 50 µg SEB, both delivered Ip. Alternatively, mice were injected with 20 mg. D-Gal and 50 µg SEB at 
the same time. All injections were delivered intraperitoneally. Mice were then monitored for the presence of ruffled fur, mucous in 
feces and lethargy. *mice had ruffled fur, mucous in feces and were lethargic. **mouse died over the course of the experiment. 
***mouse had to be euthanized due to severity of sickness.
Mice Challenge # Sick/n* # Dead/n
WT 50 µg SEB + 150 µg LPS 14/15 1/15**
ITK-/- 50 µg SEB + 150 µg LPS 11/12 1/12***
WT 50 µg SEB + 20 mg D-Gal 10/11 1/11**
ITK-/- 50 µg SEB + 20 mg D-Gal 11/11 0/11BMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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is not clear that effects seen in vitro would reflect what
happens  in vivo, since other cell-cell interactions may
allow for activation of pathways that are not seen using in
vitro activation with antibodies. Our data however, sug-
gest that indeed, ITK lies downstream of the TcR and is
required for IL-2 secretion and c-jun phosphorylation in
vivo. Corroborating a role for c-jun activation in IL-2 pro-
duction, mice carrying a dominant negative c-jun have
much reduced IL-2 secretion in vitro [28] (mice lacking c-
jun die during embryogenesis [40]). Similarly, JNK has
been implicated in IL-2 secretion by T cells in vitro [25-27].
Our data lend support to this idea that the JNK-c-jun path-
way is involved in the production of IL-2 by T cells in vivo.
Curiously, the immunosuppresant CsA has been shown
to inhibit the effects of SEB exposure in mice if delivered
prior to SEB exposure [36], however it does not inhibit
SEB induced effects in monkeys if delivered at the same
time as SEB [38]. The effects of CsA on SEB induced symp-
toms has been suggested to be due to its effects on inhib-
iting IL-2 and other cytokine production due to inhibition
of activation of the transcription factor NFAT [36,41],
however, CsA also inhibits activation of the JNK pathway
following TcR/CD3 and CD28 stimulation [29,30], and
so CsA pretreatment may act to prevent early T cell activa-
tion of these pathways, thus blocking cytokine production
and protecting mice from the effects of subsequent SEB
exposure.
Mice lacking ITK exhibit reduced T cell responses in vitro,
but also have reduced percentages of CD4+  T cells
(approximately 60–70% of WT, [16]). While this would
be expected to reduced the overall T cell response in vivo
to SEB exposure, if these cells were able to respond to SEB,
we would expect an equivalent reduction in the amount
of IL-2 secreted in vivo in response to SEB. We would also
expect to see an equivalent reduction in proliferation in
vitro. However, in vivo, we observed much reduced IL-2
secretion, and reduced expansion of Vβ8+CD4+ T cells,
although this was not as dramatic as the reduction in IL-2
secretion. Indeed, it has been observed that SEB induced T
cell expansion in IL-2 null mice, indicating that IL-2 is not
necessary for expansion of T cells in vivo following SEB
exposure. However, even with the reduced T cell responses
observed in ITK null mice, they still suffer from SEB/LPS
induced toxicity similar to that seen in the WT mice. It
should be noted however, that C57BL/6 mice are much
less sensitive to SEB induce lethal shock than Balb/c mice
[34]. Thus we observed very few deaths in our experi-
ments, and ITK may protect Balb/c mice from actual
death. We are currently crossing these mice onto the Balb/
c background to determine if this is the case.
Conclusion
In conclusion, we have show that ITK is required for IL-2
production induced by SEB in vivo and in vitro. We have
also shown that ITK may regulate signals leading IL-2 pro-
duction in part by regulating phosphorylation of c-jun.
However, mice lacking ITK exhibit similar responses to
SEB toxicity. The data suggest that the inability of T cell
lacking ITK to produce IL-2 cannot be overcome by SAG
stimulation, and that perturbing T cell activation path-
ways leading to IL-2 production does not necessarily lead
to improved responses to SEB toxicity.
Methods
Mice
Wild type mice and ITK-deficient mice (C57BL/6 back-
ground, [16]) between 8 and 10 weeks were used in all
experiments. RAG1-/- mice were a kind gift of Dr. Eric Har-
vill (Penn State University) and were similarly used
between 6–10 weeks of age. The Institutional Animal Care
and Use Committee of The Pennsylvania State University
approved all experiments.
In vivo expansion assays
WT and ITK deficient mice were injected intraperitoneally
(i.p.) with 50 µg SEB in PBS (Sigma-Aldrich, St. Louis,
MO) and after 2 days, were sacrificed and splenocytes
stained with antibodies specific for Vβ8 (SEB reactive T
cells) or Vβ6 (non-reactive T cells) and CD4 directly con-
jugated to FITC and PE respectively (BDPharmingen, San
Diego, CA). Alternatively, mice were injected i.p. with 50
µg SEB and eye-bled every 2 days for 5 days. Following
lysis of red blood cells, the remaining cells were stained as
described above for the splenocytes. Lymphocytes were
identified by flow cytometry by their forward and side
scatter characteristics.
Intracellular staining
We used a protocol reported by Zell et al to determine the
phosphorylation status of c-jun, as a measure of activation
of the JNK-c-jun pathway in SEB responding T cells. WT
and ITK deficient mice were injected i.p. or intravenously
(i.v.) with 50 µg SEB and allowed to survive for an 1 hr.
Similar results were found with both routes of administra-
tion. Animals were sacrificed and spleens, lymph nodes,
and blood rapidly isolated, and dounced in 2% parafor-
maldehyde to rapidly fix the cells as previously described
[30]. Cells were stained with antibodies to Vβ8 or Vβ6
directly conjugated to PE (BDPharmingen, San Diego,
CA), then permeabilized with saponin. Cells were then
stained for intracellular phosphorylated-c-jun with a
monoclonal antibody against phosphorylated c-jun
(IgG1, Cell Signaling, Beverly, MA), followed by
biotinylated rabbit anti-mouse IgG1 and streptavidin con-
jugated to FITC. Controls included secondary reagents
alone. Upregulation of CD69 by SEB in vivo was per-BMC Immunology 2005, 6:19 http://www.biomedcentral.com/1471-2172/6/19
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formed using similar approaches, except that T cells were
not fixed or permeabilized prior to staining with PE-con-
jugated anti-CD69 monoclonal antibody (BDPharmin-
gen, San Diego, CA). This was followed by analysis by
flow cytometry, with post analysis performed using the
WinMDI program 2.8 (The Scripps Research Institute, La
Jolla, CA).
In vitro proliferation
Lymph nodes and spleens were isolated from WT and ITK
deficient mice and pooled. Red blood cells were removed
using ACK lysis buffer, and cells resuspended in complete
RPMI. Cells were then left unstimulated or stimulated
with varying concentrations of SEB (5 µg/ml, 0.5 µg/ml,
0.05 µg/ml, 0.005 µg/ml, and 0.0005 µg/ml) at a concen-
tration of 2 × 106 cells/ml. These cells were incubated at
37°C for 5 days and pulsed once a day for 5 days with 0.5
µCi tritiated thymidine per well for 12 hrs. before harvest.
T cells were purified from WT and ITK null mice using
MiniMACS separation columns (Miltenyi Biotec Inc,
Auburn, CA), and plated at 2 × 106 cells/ml and stimu-
lated as above, in the presence of splenocytes from RAG
null mice pre-treated with mitomycin C. All experiments
were done in triplicate.
In vitro cytokine analysis
Pooled lymphocytes and splenocytes from WT and ITK
deficient mice were incubated with varying concentra-
tions of SEB (5 µg/ml, 0.5 µg/ml, 0.05 µg/ml, 0.005 µg/
ml, and 0.0005 µg/ml) for 5 days as described above for
in vitro proliferation. Supernatants were sampled once a
day over this period and analyzed for IL-2 using ELISAs
according to the manufacturer's recommendations (BDP-
harmingen, San Diego, CA).
In vivo cytokine analysis
WT and ITK deficient mice were injected with 50 µg SEB
i.v., and serum isolated from cardiac blood from mice 1,
2, 4, 8, 12, and 24 hrs. post SEB exposure and used to
perform an ELISA to determine IL-2 levels. PBS injected
mice served as controls, and there was no change in IL-2
secretion in these animals.
Statistics
Values were compared using student's t test and consid-
ered significant if p < 0.05.
List of abbreviations used
ITK Interleukin-2 inducible T cell Kinase
IL-2 Interleukin-2
SEB Staphylococcal Enterotoxin B
SAG Superantigen
Th1 T-helper 1 cells
Th2 T-helper 2 cells
Syk Spleen tyrosine kinase
Zap-70 Zeta chain Associated protein-70
Lck Lstra cell kinase
MAPK Mitogen Activated Protein Kinase
ERK Extracellular signal Regulated Kinase
JNK c-jun N-terminal kinase
NK Natural Killer cells
LCM Lymphocytic Choriomeningitis
VS Vesicular Stomatitis
PMA Phorbol Myristic Acid
PBS Phosphate Buffered Saline
NFAT Nuclear Factor of Activated T cells
AP-1 Activator protein 1
CsA Cyclosporin A
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